Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV) Meeting Abstract


Authors: Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
Abstract Title: Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 196s
Language: English
ACCESSION: WOS:000208852003060
DOI: 10.1200/jco.2010.28.15_suppl.2065
PROVIDER: wos
Notes: Meeting Abstract: 2065 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Anne S Reiner
    214 Reiner
  2. Andrew Lassman
    111 Lassman
  3. Antonio Marcilio Padula Omuro
    204 Omuro
  4. Adilia Hormigo
    49 Hormigo
  5. Lauren E Abrey
    277 Abrey
  6. Craig Nolan
    57 Nolan
  7. Mustafa Khasraw
    10 Khasraw